Cargando…
Identifying prognostic subgroups of luminal-A breast cancer using deep autoencoders and gene expressions
Luminal-A breast cancer is the most frequently occurring subtype which is characterized by high expression levels of hormone receptors. However, some luminal-A breast cancer patients suffer from intrinsic and/or acquired resistance to endocrine therapies which are considered as first-line treatments...
Autores principales: | Wang, Seunghyun, Lee, Doheon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256220/ https://www.ncbi.nlm.nih.gov/pubmed/37253056 http://dx.doi.org/10.1371/journal.pcbi.1011197 |
Ejemplares similares
-
Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016) -
Erratum to: Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups
por: Netanely, Dvir, et al.
Publicado: (2016) -
DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival
por: Fleischer, Thomas, et al.
Publicado: (2016) -
Classification of Subgroups with Immune Characteristics Based on DNA Methylation in Luminal Breast Cancer
por: Zhang, Mengyan, et al.
Publicado: (2022) -
Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers
por: Mudduwa, Lakmini, et al.
Publicado: (2017)